| Literature DB >> 34026566 |
Merel M Nap-van der Vlist1, Jan Houtveen1, Geertje W Dalmeijer2, Martha A Grootenhuis3, Cornelis K van der Ent4, Martine van Grotel3, Joost F Swart5, Joris M van Montfrans5, Elise M van de Putte1, Sanne L Nijhof1.
Abstract
OBJECTIVE: Growing up with a chronic disease comes with challenges, such as coping with fatigue. Many adolescents are severely fatigued, though its associated factors exhibit considerable interpersonal and longitudinal variation. We assessed whether PROfeel, a combination of a smartphone-based ecological momentary assessment (EMA) method using the internet, followed by a face-to-face dialogue and personalized advice for improvement of symptoms or tailor treatment based on a dynamic network analysis report, was feasible and useful. STUDYEntities:
Keywords: Adolescents; CF, cystic fibrosis; Chronic disease; EMA, ecological momentary assessments; ESR, erythrocyte sedimentation rate; Ecological momentary assessments; FEV1, forced expiratory volume in one second; Fatigue; ILD, intensive longitudinal data; JIA, juvenile idiopathic arthritis; Personalized feedback; SD, standard deviation; VAS, visual analogue scale; cJADAS, clinical Juvenile Arthritis Disease Activity Score
Year: 2021 PMID: 34026566 PMCID: PMC8131314 DOI: 10.1016/j.invent.2021.100395
Source DB: PubMed Journal: Internet Interv ISSN: 2214-7829
Examples of cases with quotes and graphs from the personalized report.
| Case description | Quote | Example network technical report (results only shown when positive estimates (black) or negative estimates (red) > 0.1 and significant) | Example graph personalized report |
|---|---|---|---|
| 1. 16 year old girl with medically unexplained back pain and fatigue. The personalized report shows more fatigue when mental activity is low. During the conversation we discovered that low mental inactivity for her meant also the absence of distraction. She concluded that distraction helps her to take her attention of her symptoms, which may help her. She was referred to a psychologist, with whom she is going to explore how she can use this knowledge to alleviate her symptoms. | |||
| 2. 17 year old girl with juvenile idiopathic arthritis. The personalized report shows a contemporaneous association between more fatigue and more mental activity and between more fatigue and more contact with people who bothered her or did not understand her. During our conversation she tells us that she often feels overstimulated in a busy environment by noises, emotions or talk. She concludes that she would be helped if someone could coach her on how to filter and regulate the incoming stimuli, so that they will cost her less energy. | |||
| 3. 14 year old girl with Hashimoto thyreoiditis. The personalized report shows that increased mental activity precedes more headache and more restrictions related to her symptoms, while being more physical activity precedes less headache and less restrictions. She tells us that she recognizes herself in this pattern, but she finds it really hard to motivate herself to get more physically active. She finds the possibility of cognitive behavioral therapy with graded exercise an option that may fit her needs. | |||
| 4. 18 year old girl with prescleroderma. The personalized report shows that she has more pain in the weekends and when she is physically active. She tells us she intensively exercises in the weekend. She knows she will have more pain then, but accepts it in order to be able to play the hockey games. She does not want to change this. Furthermore, more worrying is followed in time by more fatigue. She tells us that she recognizes that her thinking can be really preoccupied every now and then. She did not make the link to fatigue before, but she is open to consider it as a possible treatment target. |
Baseline characteristics of participants.
| Chronic disease groups | Adolescents with unexplained fatigue | |||
|---|---|---|---|---|
| Adolescents with CF (N = 10) | Adolescents with autoimmune disease (N = 18) | Adolescents post-cancer treatment (N = 3) | Adolescents with medically unexplained fatigue (N = 26) | |
| Age (mean ± SD) | 16.9 ± 1.6 | 16.2 ± 1.8 | 15.1 ± 1.7 | 16.0 ± 1.4 |
| Sex, female (N, %) | 9 (90%) | 16 (89%) | 3 (100%) | 20 (77%) |
| Diagnosis | 4 (40%) homozygous dF508 mutation | 3 (17%) poly JIA | 1 (33%) solid tumors | NA |
| Duration of disease, years | 16.9 ± 1.6 | 5.2 ± 4.0 | 0.9 ± 0.8 | NA |
| Disease activity | FEV1%: 69.5 ± 15.1 | cJADAS: 2 (0–9) | All post-cancer treatment and in remission | NA |
Duration of disease: years since diagnosis until inclusion for adolescents with JIA; years from end of treatment until inclusion for adolescents post-cancer treatment.
If the data were normally distributed, the mean ± SD is given; if not, the median and interquartile range is given.CF = cystic fibrosis; SD = standard deviation; JIA = juvenile idiopathic arthritis; cJADAS = clinical Juvenile Arthritis Disease Activity Score; ESR = erythrocyte sedimentation rate; FEV1% = predicted percentage of forced expiratory volume in one second; NA = not applicable.
Fig. 1Total amount of EMA measurements in all participants per day. The red line indicates the desired measurement period of six weeks.
Usefulness and feasibility of the EMA.
| Ranking | Clarity of EMA (n = 50) | User friendliness (n = 50) | Burden of filling out EMA during measurement period (n = 46) | Would recommend app (n = 47) |
|---|---|---|---|---|
| Very bad (0–2) | 0 | 0 | 1 (2%) | 2 (not at all; 4%) |
| Bad (3–4) | 0 | 0 | 2 (4%) | 0 (no) |
| Medium (5–6) | 2 (4%) | 0 | 10 (22%) | 5 (maybe; 9%) |
| Good (7–8) | 22 (44%) | 20 (40%) | 16 (35%) | 16 (most likely; 34%) |
| Very good (9–10) | 26 (52%) | 30 (60%) | 17 (37%) | 24 (definitely; 51%) |
Usefulness and feasibility of the personalized report.
| Ranking | Recognition of personalized report (n = 44) | Comprehensibility of report (n = 42) | Insight in symptoms (n = 48) | Report enabled steps towards treatment (n = 40) |
|---|---|---|---|---|
| Very bad (0–2) | 1 (2%) | 1 (2%) | 9 (19%) | 8 (20%) |
| Bad (3–4) | 0 | 0 | 1 (2%) | 2 (5%) |
| Medium (5–6) | 1 (2%) | 5 (12%) | 7 (15%) | 5 (13%) |
| Good (7–8) | 14 (32%) | 11 (26%) | 17 (35%) | 15 (38%) |
| Very good (9–10) | 28 (64%) | 25 (60%) | 14 (29%) | 10 (25%) |